UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000005903
Receipt No. R000006982
Scientific Title Multicenter Phase II Clinical Study on the Safety and Efficacy of Nilotinib in Patients with Chronic Myelogenous Leukemia-Chronic Phase and Major Molecular Response
Date of disclosure of the study information 2011/07/01
Last modified on 2019/02/26 01:20:36

No. Disposal Last modified on Item of update
1 Insert 2011/07/01 20:56:20
2 Update 2011/07/01 21:29:58 Key inclusion criteria
3 Update 2011/07/29 21:24:40 Classification by malignancy
4 Update 2012/01/10 20:39:35 Key inclusion criteria
Key inclusion criteria
5 Update 2012/01/10 20:44:42 TEL
Institute
Institute
Organization
Organization
Category of Funding Organization
Tel1
6 Update 2012/07/02 15:01:01 Recruitment status
Date of protocol fixation
Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
Results
Results
7 Update 2012/07/02 15:10:24 Recruitment status
Date of protocol fixation
Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
Results
Results
8 Update 2013/01/01 14:29:09 Recruitment status
9 Update 2014/01/01 12:10:07 TEL
Email
Address
Address
TEL
10 Update 2014/10/27 22:27:33 Last name of lead principal investigator
Last name of lead principal investigator
TEL
Email
11 Update 2014/10/27 22:34:15 Public title
12 Update 2014/10/27 22:40:06 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
13 Update 2016/01/01 11:14:04 Recruitment status
Date trial data considered complete
Date analysis concluded
Publication of results
Results
Results
14 Update 2018/11/07 15:22:53 Name of primary sponsor
Organization
15 Update 2019/02/26 01:20:36 URL related to results and publications


Contact us.